title: Polidocanol sclerotherapy for hydroceles and epididymal cysts.
abstract: A total of 87 patients with 63 hydroceles and 29 epididymal cysts underwent injection sclerotherapy with polidocanol on an outpatient basis. In the hydrocele group the cure rate after 1 treatment was 67% and the overall cure rate was 87% after a median followup of 14 months. In the group treated for epididymal cyst the corresponding cure rates were 46% and 64%, respectively, with a median followup of 12 months. A low rate of complications was observed. Of 86 evaluable patients 81 (94%) were satisfied with the procedure and the treatment results. Therefore, we recommend injection sclerotherapy with polidocanol as primary treatment for hydroceles and epididymal cysts in patients older than 40 years.
authors.affiliation: Department of Urology, Orebro Medical Center, Sweden.
authors.forename: T
authors.initials: T
authors.lastname: Sigurdsson
authors.forename: J E
authors.initials: JE
authors.lastname: Johansson
authors.forename: S
authors.initials: S
authors.lastname: Jahnson
authors.forename: F
authors.initials: F
authors.lastname: Helgesen
authors.forename: S O
authors.initials: SO
authors.lastname: Andersson
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003560:Cysts / Q000628:therapy*; D004822:Epididymis; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D011446:Prospective Studies; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D015911:Sclerotherapy; D013733:Testicular Diseases / Q000628:therapy; D006848:Testicular Hydrocele / Q000628:therapy*
chemical_list: D012597:Sclerosing Solutions; D000077423:Polidocanol; D011092:Polyethylene Glycols